Deoxycholic Acid

CHEMBL406393 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
392.6 g/mol
LogP
4.9
Phase
4

A naturally occurring bile acid that disrupts and destroys fat cell membranes, used as an injectable treatment to reduce submental fat (the double chin) under the jaw. The destroyed fat cells are permanently eliminated by the body's immune system. Injections can cause swelling, numbness, and bruising, and multiple treatment sessions are typically needed.

Molecular Weight

392.6000 g/mol

LogP

4.90

TPSA

77.80 Ų

Lipinski RO5

Pass

Therapeutic Areas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C

InChI

InChI=1S/C24H40O4/c1-14(4-9-22(27)28)18-7-8-19-17-6-5-15-12-16(25)10-11-23(15,2)20(17)13-21(26)24(18,19)3/h14-21,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15-,16-,17+,18-,19+,20+,21+,23+,24-/m1/s1

Molecular Formula

C24H40O4

HBD / HBA

3 / 4

Rotatable Bonds

4

Heavy Atoms

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

A naturally occurring bile acid that disrupts and destroys fat cell membranes, used as an injectable treatment to reduce submental fat (the double chin) under the jaw. The destroyed fat cells are permanently eliminated by the body's immune system. Injections can cause swelling, numbness, and bruising, and multiple treatment sessions are typically needed.

Yes, Deoxycholic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL406393. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 222528. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.